YOUR BUSINESS AUTHORITY
Springfield, MO
Novo Nordisk shares jumped 14% on news of drug trial results for its once weekly amycretin obesity drug.
Trial participants had an average weight reduction of 22%.
The company's stock is reportedly on track for its biggest daily gain since August 2023.
Read more from CNBC.
Organizers hope to bolster client traffic to center city businesses.
AI expert gives advice at SBJ's People You Need to Know
European-style Christmas market to make debut in Branson next week
Big Cedar Lodge golf courses place on Golfweek list
Original, historic Pipkin building up for sale
Pizza Hut co-founder Dan Carney dies
Annual downtown holiday events combine for Nov. 21 celebration